The latest closing stock price for SAB Biotherapeutics as of February 21, 2025 is 1.82.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-751 today, roughly -1 times their original investment - a -37.06% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.30, which is 246.2% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.60, which is 12.1% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.35.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-751 today, roughly -1 times their original investment - a -37.06% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.30, which is 246.2% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 1.60, which is 12.1% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.35.